Press Releases

Deal making in the biosimilars market: increasing investment for decreasing return? - DataMonitor

Feb 05, 2013 08:09 GMT BioProcess International Europe Conference and Exhibition Biosimilars are big business. The global biologics market reached $125 billion in 2011, and is predicted to top $150 billion by the end of 2016. Of this, roughly $60 billion will be in off-patent sales.

ADC manufacturing made rapid progress over last five years, says Seattle Genetics

Jan 31, 2013 08:00 GMT BioProcess International Europe Conference and Exhibition Exclusive Interview with Nathan Ihle, Executive Director, Process Chemistry & Analytical Biochemistry, Seattle Genetics, USA

Peter Greenleaf steps down as MedImmune president, Bahija Jallal chosen as replacement

Dec 18, 2012 15:00 GMT Companiesandmarkets.com

Dec 17, 2012 16:30 GMT Companiesandmarkets.com

Dec 13, 2012 14:26 GMT Companiesandmarkets.com

SEKAB launches web pages on sustainability

Dec 13, 2012 12:59 GMT SEKAB To be able to tell you more about our sustainability efforts SEKAB is launching a section on the website dedicated solely to sustainability. SEKAB is one of the largest green tech companies in Sweden and we want to make our contribution to raising the issue of what companies can do to increase awareness of sustainability issues.

Dec 11, 2012 14:52 GMT Companiesandmarkets.com

Dec 10, 2012 09:56 GMT Companiesandmarkets.com

Dec 06, 2012 14:39 GMT Companiesandmarkets.com